EUVIMEDEUVIMED entdecken
Leserbrief

Treatment of Netherton syndrome with spesolimab

Juan Bai iD, Xinyi Chen, Jianjun Qiao iD, Hong Fang

Journal of the European Academy of Dermatology and Venereology · 2025-03 · 39 (3)

DOI: 10.1111/jdv.20244 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 29.07.2024. Verfasst von Juan Bai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Juan Bai, Jianjun Qiao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Bai, J., Chen, X., Qiao, J., & Fang, H. (2025). Treatment of Netherton syndrome with spesolimab. Journal of the European Academy of Dermatology and Venereology, 39(3). https://doi.org/10.1111/jdv.20244

Vancouver

Bai J, Chen X, Qiao J, Fang H. Treatment of Netherton syndrome with spesolimab. Journal of the European Academy of Dermatology and Venereology. 2025;39(3). doi:10.1111/jdv.20244

BibTeX
@article{Bai2025,
  author = {Bai, Juan and Chen, Xinyi and Qiao, Jianjun and Fang, Hong},
  title = {Treatment of Netherton syndrome with spesolimab},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  volume = {39},
  number = {3},
  doi = {10.1111/jdv.20244}
}
Kostenlos starten →